http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1861121-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cee50211914c19ccaabc85c6bc50fb72 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 |
filingDate | 2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86a9c2d801155c5dcd4f0aed52d55e52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_541c1ba70ba47218248c0c06c7e65e13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2410240f9893bfd8e166c0c6cb73c9bb |
publicationDate | 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1861121-A1 |
titleOfInvention | Hiv vaccine composition |
abstract | An anti-HIV vaccine composition is disclosed. The vaccine comprises an combination of immunogenic peptide mixtures, which mixtures may be prepared in a single synthesis. The composition collectively represents the in vivo variability seen in immunogenic epitopes from highly variable regions of HIV. Immunization with the vaccine elicits broadly reactive immunity (CTL and T helper cell responses) against the divergent strains of HIV upon which it is based. The vaccine may be formulated to target regionally distinct variability based on an HIV clade predominant in a geographical region. |
priorityDate | 2005-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.